Improving patient outcomes with AI-powered pathology.
Boston, MA
Joined March 2016
- Tweets517
- Following55
- Followers2.5K
- Likes136
PathAI retweeted
The opportunity to standardize the way we construct data sets is important...If we try to build a data set for every use case, we can set ourselves up to fail. We don't want to build a large reference data set that doesn't get used - @balasubramaniac from @Path_AI #FriendDx
PathAI retweeted
At #SABCS24 today, David Rimm @RimmPathology @YaleMed, @DrKimAllison, Reena Philip of @US_FDA, Andy Beck of @Path_AI & Giuseppe Viale of @IEOufficiale, discuss the importance measuring w/quantitative assays #BreastCancer.
PathAI retweeted
New @CancerReserch findings in @JCO_ASCO examine variability in HRD results across assays, suggesting the need for consistent & aligned strategies in biomarker selection for #clinicaltrials & clinical decision-making. #jcooa
Read the manuscript here: ascopubs.org/doi/10.1200/OA-…
PathAI retweeted
We are excited to announce our partnership with @Path_AI, bringing their AISight® Image Management System and advanced AI technology into our pathology services.
Click the link to read the full press release:
viziadx.com/vizia-diagnostic…
#ViziaDiagnostics #PathAI #partnership
PathAI retweeted
#DIGITALPATH Importance of AI Fluency in the era of Digital and Computational Pathology
(Dr. Eric Walk , MD, FCAP, Chief Medical Officer, @Path_AI )
🗓️ August 27, 2024 - 12:00 PM (ET, NYC)
PathAI retweeted
@Path_AI has innovations in quantifying PDL-1, HER 2 score, MASH score, and characterizing IBD and tumor microenvironment. Great to hear more this morning:
#DIGITALPATH Importance of AI Fluency in the era of Digital and Computational Pathology
(Dr. Eric Walk , MD, FCAP, Chief Medical Officer, @Path_AI )
🗓️ August 27, 2024 - 12:00 PM (ET, NYC)
PathAI retweeted
Using data from MASH clinical trials, an AI model shows comparable performance with respect to individual pathologists in assessing histologic scoring for enrollment criteria and endpoint evaluation @Path_AI
nature.com/articles/s41591-0…
PathAI retweeted
#AI-based (AIM) tool for scoring in metabolic dysfunction-associated steatohepatitis #liver biopsies aids consensus if path Drs' interpretations vary. Image & research Janani Iyer, @dinkar_juyal, Quang Le, Zahil Shanis et al @Path_AI in @NatureMedicine On bpod.org.uk/archive/2024/8/1…
PathAI retweeted
Using data from MASH clinical trials, an AI model shows comparable performance with respect to individual pathologists in assessing histologic scoring for enrollment criteria and endpoint evaluation @Path_AI
nature.com/articles/s41591-0…
PathAI retweeted
🔥 Kick off summer with a Fireside Chat on #DigitalPathology featuring our CEO, Andy Beck!
Join Andy and an incredible lineup of #GoogleCloud experts, partners, and customers at the #Healthcare and Life Sciences Summer Camp. #AI
Sign up here: lnkd.in/ecV5VK_R
PathAI retweeted
Do you know your #CNN from your #GAN? Does deep learning make you want to dive for cover? Eric Walk of @Path_AI encourages even the biggest technophobes to start learning the language of #AI 💬 bit.ly/3TEkPlk
PathAI retweeted
But can we prevent even the few recurrences seen in the trial?
We conducted multiomic analyses to find an answer.
In collab with @Path_AI we used ML-algorithms on HER2 slides, unveiling extensive heterogeneity in HER2 expressing patterns
👉HER2+ BC is NOT one disease! 4/10
PathAI retweeted
Looking forward to sharing some of the recent innovative work at @PathAI on AI-powered pathology in the GI space. Thank you @AIGImed’s organizing committee for the invite.
#AIpoweredPathology #Medicalinnovation #precisionmedicine
PathAI retweeted
Excited to announce our partnership w/@Path_AI, a global leader in AI-powered pathology, to deliver solutions combining AI-derived structured pathology & multimodal #RWD to accelerate the discovery & development of new treatments for patients with #cancer. asterinsights.com/pathai-and…
PathAI retweeted
It was a pleasure sharing my insights during a panel discussion in DC #DDW24, hosted by @Path_AI and @FNIH_Org. Our conversation centered on the role of histology in UC clinical trials and the multifaceted challenges we encounter in the field.
#pathology #UC #Innovation #AI
PathAI retweeted
Starting at 10 AM ET: Reporter @ampressman moderates a virtual panel on how Massachusetts can become the nation's premiere artificial intelligence hub. Sign up for free and hear from Sec. Yvonne Hao, Emily Capodilupo of @WHOOP, and Andy Beck @Path_AI: trib.al/Uwe0Kr9
PathAI retweeted
Today we released PLUTO - a scalable Foundation Model for pathology images. Some highlights from training this model (1/n):
#FoundationModels usher in a new era of #MachineLearning & allows the development of new AI products that can handle diverse tasks with exceptional performance. PLUTO was trained using self-supervision & can be adapted to handle a range of pathology tasks at different scales
PathAI retweeted
PLUTO - our Pathology #foundationmodel specifically designed to be performant, compact, and generalizable. It's been an honor to help the guide the PLUTO direction. Our manuscript can be found here: lnkd.in/eHqtBBqW
Introducing PLUTO, an #AI foundation model developed for #ComputationalPathology.
Multi-resolution custom training architecture, diverse high-quality data, and inference efficiency boosts performance to extract meaningful insights for #PrecisionMedicine. pathai.com/resources/pathai-…
PathAI retweeted
Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study - ScienceDirect; the future of assessment of pathological response? sciencedirect.com/science/ar…
PathAI retweeted
NEW EPISODE! @PrecisionRx talks with Dr. @AndyBeck, CEO of @Path_AI, a leading digital pathology company. PathAI is changing the game with #digitalpathology, creating AI-based model insights & changing how clinical development occurs. Listen below:
hubs.ly/Q01N2n9l0